GVK Bio gets approvals

Hyderabad: The Clinical Pharmacology Unit (CPU) of GVK Biosciences (GVK BIO) received approvals from all major regulatory bodies globally including the US FDA and the WHO. The approvals open global markets to GVK BIO’s clients in the US, Europe and Latin American countries in addition to the domestic sector. Mr Manni Kantipudi, President of GVK BIO, said the company has built a new Bioanalytical facility in addition to the existing one to cater to the growing business demands. GVK BIO is also setting up its own Clinical Laboratory and aims for an early accreditation.